EMCV-LZn is unable to suppress PKR activation and downstream stress granule formation, and fails to induce NCTD to suppress IFN-β production, thereby allowing the activation of these two important antiviral pathways during infection [30,39]. The gene discussed is EIF2AK2; the disease is infection.